Fifty-one patients with chronic obstructive lung disease with a proven bacterial respiratory tract infection were treated with ciprofloxacin 500 mg twice daily or 750 mg twice daily. Both dosages were given orally for approximately 10 days. The higher dosage showed a reduced amount of reinfections and relapses (19% and 16% versus 5% and 0%). The overall results were the same in both groups. Adverse reactions were mild: nausea and visual disturbances were seen in five patients. Eights patients had slight liver test abnormalities. In one patient a seizure occurred. All adverse reactions were of a temporary nature.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Ingram RH Jr. Chronic bronchitis, emphysema, and airways obstruction. In: Petersdorf RO, Adams RO, Braunwals E, Isselbacher KJ, Martin JB, Wilson JD, eds. Harrison's principles of internal medicine. 10th ed. New York: McGraw-Hill Book Co., 1983:1550.
Rose RM, Pinkston P, O'Donnell C, Jensen A. Viral infection of the lower respiratory tract. Clin Chest Med 1987;8:411.
Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanism of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis 1976;113:131–9.
Smith CB, Kanner RE, Golden CA, Klauber MR, Renzetti AD Jr. Effect of viral infection on pulmonary diseases. J Infect Dis 1980;141:271–80.
Chodosh S. Acute bacterial exacerbations in bronchitis and asthma. Am J Med 1987;82:156–63.
Davies BI, Maesen FPV. Quinolones in chest infections. J Antimicrob Chemother 1986;18:296–9.
Haverkorn MJ. Ciprofloxacin therapy of respiratory tract infection withPseudomonas aeruginosa. Eur J Clin Microb 1988;7:661–4.
Hoogkamp-Korstanje JAA, Klein SJ. Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin. Pharm Weekbl [Sci] 1987;9(Suppl):60–3.
Wijnands WJA, Vree TB, Baars AM, Van Herwaarden CLA. The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophyl-line. Pharm Weekbl [Sci] 1987;9(Suppl):72–5.
Raoof S, Wollschlager CM, Khan FA. Ciprofloxacin increases serum theophylline levels. Chest 1985;88:32.
Davies BI, Maesen FPV, Baur C. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. Eur J Clin Microb 1986;5:226–31.
About this article
Cite this article
de la Rivière, T.B., Daniëls-Bosman, M.S.M. & ten Velde, G.P.M. Two different dosages of ciprofloxacin in patients with respiratory tract infections. Pharmaceutisch Weekblad Scientific Edition 11, 121–123 (1989). https://doi.org/10.1007/BF01987955
- Pulmonary diseases, chronic obstructive
- Respiratory tract infections